Duloxetine (Synonyms: LY248686)

Name: Duloxetine
Brand: MedChemExpress
SKU: HY-B0161
Rating: 5.0 (12 reviews)

Cat. No.: HY-B0161 Purity: 99.92%: Data Sheet
COA

SDS
Handling Instructions
FAQs
Technical Support

Duloxetine is a serotonin-norepinephrine reuptake inhibitor with a K_i of 4.6 nM, used for treatment of major depressive disorder and generalized anxiety disorder (GAD).

For research use only. We do not sell to patients.

CAS No. : 116539-59-4

Size	Stock	Quantity
Oil + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO ready for reconstitution	In-stock	Estimated Time of Arrival: December 31
Solution
10 mM * 1 mL in DMSO	In-stock	Estimated Time of Arrival: December 31
Oil
5 mg	In-stock	Estimated Time of Arrival: December 31
10 mg	In-stock	Estimated Time of Arrival: December 31
25 mg	In-stock	Estimated Time of Arrival: December 31
50 mg	In-stock	Estimated Time of Arrival: December 31
100 mg	In-stock	Estimated Time of Arrival: December 31
200 mg	Get quote
500 mg	Get quote

or Bulk Inquiry

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 12 publication(s) in Google Scholar

Other Forms of Duloxetine:

Duloxetine-d₇ In-stock
Duloxetine metabolite Para-Naphthol Duloxetine In-stock
Duloxetine hydrochloride In-stock
Duloxetine-d₇ hydrochloride Get quote
(R)-Duloxetine Get quote
(R)-Duloxetine hydrochloride Get quote
(±)-Duloxetine hydrochloride Get quote
Duloxetine-d₅ oxalate Get quote

12 Publications Citing Use of MCE Duloxetine

Cell Proliferation/Viability Assay

Cell Imaging/Staining

Flow Cytometry

: Duloxetine purchased from MedChemExpress. Usage Cited in: Autophagy. 2026 Mar 5. [Abstract]; Duloxetine hydrochloride (Duloxetine Hcl; 10 μM; 15 h) increased LC3-II levels incubated neurons in a nutrient-limited medium (nutrient deprivation, ND).

: Duloxetine purchased from MedChemExpress. Usage Cited in: Autophagy. 2026 Mar 5. [Abstract]; Duloxetine hydrochloride (Dulox.; 10 μM; 15 h) showed the average number of LAMP1+ puncta did not change in response to these treatments, we observed a significant swelling of LAMP1+ vesicles in Neuro-2a cells.

: Duloxetine purchased from MedChemExpress. Usage Cited in: Autophagy. 2026 Mar 5. [Abstract]; Duloxetine hydrochloride (Dulox.; 10 μM; 15 h) induced enlargement of the lysosome in Neuro-2a cells.

: Duloxetine purchased from MedChemExpress. Usage Cited in: Neurotox Res. 2020 Dec;38(4):859-870. [Abstract]; Duloxetine hydrochloride (Duloxetine; 0-100 μM; 24 h) inhibited cell viability in N2a cells (a) and C17.2 cells (b).

: Duloxetine purchased from MedChemExpress. Usage Cited in: Neurotox Res. 2020 Dec;38(4):859-870. [Abstract]; Duloxetine hydrochloride (Duloxetine; 0, 12.5, 25, 50, 100 μM; 24 h) inhibited N2a cells and C17.2 cells viability in a dose-dependent manner.

: Duloxetine purchased from MedChemExpress. Usage Cited in: Neurotox Res. 2020 Dec;38(4):859-870. [Abstract]; Duloxetine hydrochloride (Duloxetine; 0, 12.5, 25, 50, 100 μM; 24 h) inhibited N2a viability in a dose-dependent manner.

Featured Recommendations

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

Biological Activity
Purity & Documentation
References
Customer Review

Description

Duloxetine is a serotonin-norepinephrine reuptake inhibitor with a K_i of 4.6 nM, used for treatment of major depressive disorder and generalized anxiety disorder (GAD)^[1]^[2].

Cellular Effect

Cell Line	Type	Value	Description	References
CHO	IC₅₀	>1000 nM Compound: 2	Displacement of [3H]WIN-35428 form human DAT expressed in CHO cell membranes Displacement of [3H]WIN-35428 form human DAT expressed in CHO cell membranes	[PMID: 20378347]
CHO	IC₅₀	2.8 μM Compound: duloxetine	Inhibition of Cav1.2 current measured using QPatch automatic path clamp system in CHO cells expressing Cav1.2, beta-2 and alpha-2/delta-1 subunits Inhibition of Cav1.2 current measured using QPatch automatic path clamp system in CHO cells expressing Cav1.2, beta-2 and alpha-2/delta-1 subunits	[PMID: 23812503]
HEK293	IC₅₀	19 nM Compound: duloxetine	Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells	[PMID: 16750359]
HEK293	IC₅₀	6 nM Compound: duloxetine	Inhibition of [3H]5-HT uptake at 5HT transporter expressed in HEK293 cells Inhibition of [3H]5-HT uptake at 5HT transporter expressed in HEK293 cells	[PMID: 16750359]
HEK293	IC₅₀	870 nM Compound: duloxetine	Inhibition of DA transporter expressed in HEK293 cells Inhibition of DA transporter expressed in HEK293 cells	[PMID: 16750359]
HEK293	IC₅₀	19 nM Compound: duloxetine	Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells	[PMID: 16750363]
HEK293	IC₅₀	6 nM Compound: duloxetine	Inhibition of [3H]5-HT reuptake at 5HT transporter in HEK293 cells Inhibition of [3H]5-HT reuptake at 5HT transporter in HEK293 cells	[PMID: 16750363]
HEK293	IC₅₀	870 nM Compound: duloxetine	Inhibition of [3H]DA reuptake at DA transporter in HEK293 cells Inhibition of [3H]DA reuptake at DA transporter in HEK293 cells	[PMID: 16750363]
HEK293	IC₅₀	19 nM Compound: duloxetine	Inhibition of [3H]NA from human NET expressed in HEK293 cells Inhibition of [3H]NA from human NET expressed in HEK293 cells	[PMID: 17267217]
HEK293	IC₅₀	6 nM Compound: duloxetine	Inhibition of [3H]5-HT from human SERT expressed in HEK293 cells Inhibition of [3H]5-HT from human SERT expressed in HEK293 cells	[PMID: 17267217]
HEK293	IC₅₀	870 nM Compound: duloxetine	Inhibition of [3H]DA from human DAT expressed in HEK293 cells Inhibition of [3H]DA from human DAT expressed in HEK293 cells	[PMID: 17267217]
HEK293	IC₅₀	6.6 nM Compound: 7	Displacement of [alpha,beta-3H(N)]-5-hydroxytryptamine from human cloned SERT expressed in HEK293 cells by microplate scintillation counter Displacement of [alpha,beta-3H(N)]-5-hydroxytryptamine from human cloned SERT expressed in HEK293 cells by microplate scintillation counter	[PMID: 18954038]
HEK293	IC₅₀	660 nM Compound: 7	Displacement of 3,4-[ring-2,5,6-3H]dihydroxyphenylethylamine from human cloned DAT expressed in HEK293 cells by microplate scintillation counter Displacement of 3,4-[ring-2,5,6-3H]dihydroxyphenylethylamine from human cloned DAT expressed in HEK293 cells by microplate scintillation counter	[PMID: 18954038]
HEK293	IC₅₀	8.9 nM Compound: 7	Displacement of Levo[ring-2,5,6-3H]norepinephrine from human cloned NET expressed in HEK293 cells by microplate scintillation counter Displacement of Levo[ring-2,5,6-3H]norepinephrine from human cloned NET expressed in HEK293 cells by microplate scintillation counter	[PMID: 18954038]
HEK293	IC₅₀	4 nM Compound: 2	Inhibition of [3H]5-HT uptake at human 5HTT expressed in HEK293 cells Inhibition of [3H]5-HT uptake at human 5HTT expressed in HEK293 cells	[PMID: 19359175]
HEK293	IC₅₀	5 nM Compound: 2	Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells	[PMID: 19359175]
HEK293	IC₅₀	590 nM Compound: 2	Inhibition of [3H]DA uptake at human DAT expressed in HEK293 cells Inhibition of [3H]DA uptake at human DAT expressed in HEK293 cells	[PMID: 19359175]
HEK293	IC₅₀	2.3 nM Compound: 5	Displacement of [3H]citalopram from human SERT transfected in HEK293 cells after 3 hrs by Wallac counting analysis Displacement of [3H]citalopram from human SERT transfected in HEK293 cells after 3 hrs by Wallac counting analysis	[PMID: 24900709]
HEK293	IC₅₀	29 nM Compound: 5	Displacement of [3H]Nisoxetine from human NET transfected in HEK293 cells after 3 hrs by Wallac counting analysis Displacement of [3H]Nisoxetine from human NET transfected in HEK293 cells after 3 hrs by Wallac counting analysis	[PMID: 24900709]
HEK293	IC₅₀	10.4 nM Compound: Duloxetine	Inhibition of serotonin reuptake at human SERT expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay Inhibition of serotonin reuptake at human SERT expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay	[PMID: 24974340]
HEK293	IC₅₀	515 nM Compound: Duloxetine	Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay	[PMID: 24974340]
HEK293	IC₅₀	977 nM Compound: Duloxetine	Inhibition of DA reuptake at human DAT expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay Inhibition of DA reuptake at human DAT expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay	[PMID: 24974340]
HEK293	IC₅₀	10.4 nM Compound: duloxetine	Inhibition of human SERT expressed in HEK293 cells at incubated for 15 mins by neurotransmitter reuptake assay Inhibition of human SERT expressed in HEK293 cells at incubated for 15 mins by neurotransmitter reuptake assay	[PMID: 25221656]
HEK293	IC₅₀	515 nM Compound: duloxetine	Inhibition of human NET expressed in HEK293 cells at incubated for 15 mins by neurotransmitter reuptake assay Inhibition of human NET expressed in HEK293 cells at incubated for 15 mins by neurotransmitter reuptake assay	[PMID: 25221656]
HEK293	IC₅₀	977 nM Compound: duloxetine	Inhibition of human DAT expressed in HEK293 cells at incubated for 15 mins by neurotransmitter reuptake assay Inhibition of human DAT expressed in HEK293 cells at incubated for 15 mins by neurotransmitter reuptake assay	[PMID: 25221656]
JAR	IC₅₀	3 nM Compound: 3	Inhibition of serotonin uptake at human SERT expressed in JAR cells Inhibition of serotonin uptake at human SERT expressed in JAR cells	[PMID: 18771916]
JAR	IC₅₀	3 nM Compound: 5	Inhibition of serotonin uptake at human SERT expressed in human JAR cells Inhibition of serotonin uptake at human SERT expressed in human JAR cells	[PMID: 19329313]
JAR	IC₅₀	3 nM Compound: 2	Inhibition of human SERT expressed in human JAR cells Inhibition of human SERT expressed in human JAR cells	[PMID: 20378347]
MDCK	IC₅₀	4 nM Compound: 3	Inhibition of norepinephrine uptake at human NET expressed in MDCK cells Inhibition of norepinephrine uptake at human NET expressed in MDCK cells	[PMID: 18771916]

In Vitro

Duloxetine ((S)-Duloxetine) inhibits the reuptake of serotonin and norepinephrine in the central nervous system. Duloxetine is also considered a less potent inhibitor of dopamine reuptake. However, duloxetine has no significant affinity for dopaminergic, adrenergic, cholinergic, histaminergic, opioid, glutamate, and GABA receptors and can therefore be considered to be a selective reuptake inhibitor at the 5-HT and NA transporters. Duloxetine undergoes extensive metabolism, but the major circulating metabolites do not contribute significantly to the pharmacologic activity. Major depressive disorder is believed to be due in part to an increase in pro-inflammatory cytokines within the central nervous system. Antidepressants including ones with a similar mechanism of action as duloxetine, i.e. serotonin metabolism inhibition, cause a decrease in proinflammatory cytokine activity and an increase in anti-inflammatory cytokines; this mechanism may apply to duloxetine in its effect on depression but research on cytokines specific to duloxetine therapy is lacking^[1].
The analgesic properties of duloxetine in the treatment of diabetic neuropathy and central pain syndromes such as fibromyalgia are believed to be due to sodium ion channel blockade^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Clinical Trial

Molecular Weight

297.41

Formula

C₁₈H₁₉NOS

CAS No.

116539-59-4

Appearance

Oil

Color

Light brown to yellow

SMILES

CNCC[C@H](OC1=CC=CC2=C1C=CC=C2)C3=CC=CS3

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

4°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

Solvent & Solubility

In Vitro:

DMSO : 100 mg/mL (336.24 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions

Concentration Solvent Mass	1 mg	5 mg	10 mg

1 mM	3.3624 mL	16.8118 mL	33.6236 mL
5 mM	0.6725 mL	3.3624 mL	6.7247 mL
10 mM	0.3362 mL	1.6812 mL	3.3624 mL

View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Molarity Calculator
Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

This equation is commonly abbreviated as: C₁V₁ = C₂V₂

Concentration _(start)

Volume _(start)

Concentration _(final)

Volume _(final)

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 5 mg/mL (16.81 mM); Clear solution

This protocol yields a clear solution of ≥ 5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (50.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Protocol 2

Add each solvent one by one: 10% DMSO 90% Corn Oil
Solubility: ≥ 5 mg/mL (16.81 mM); Clear solution

This protocol yields a clear solution of ≥ 5 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (50.0 mg/mL) to 900 μL Corn oil, and mix evenly.

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Please enter your animal formula composition:

DMSO +

Tween-80 +

Saline

Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.

The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).

Calculation results:

Working solution concentration: mg/mL

Method for preparing stock solution: mg drug dissolved in μL DMSO (Stock solution concentration: mg/mL).

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).

Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.

If the continuous dosing period exceeds half a month, please choose this protocol carefully.

Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.

Purity & Documentation

Purity: 99.92%

Select Batch:

Data Sheet (278 KB) SDS (393 KB)

COA (254 KB) HNMR (141 KB) RP-HPLC (139 KB) LCMS (106 KB)

Handling Instructions (2659 KB)

References

[1]. De Berardis, D., et al., The effect of newer serotonin-noradrenalin antidepressants on cytokine production: a review of the current literature. Int J Immunopathol Pharmacol, 2010. 23(2): p. 417-22. [Content Brief]

[2]. Wang, S.Y., J. Calderon, and G. Kuo Wang, Block of neuronal Na+ channels by antidepressant duloxetine in a state-dependent manner. Anesthesiology, 2010. 113(3): p. 655-65. [Content Brief]

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg

DMSO	1 mM	3.3624 mL	16.8118 mL	33.6236 mL	84.0590 mL
	5 mM	0.6725 mL	3.3624 mL	6.7247 mL	16.8118 mL
	10 mM	0.3362 mL	1.6812 mL	3.3624 mL	8.4059 mL
	15 mM	0.2242 mL	1.1208 mL	2.2416 mL	5.6039 mL
	20 mM	0.1681 mL	0.8406 mL	1.6812 mL	4.2030 mL
	25 mM	0.1345 mL	0.6725 mL	1.3449 mL	3.3624 mL
	30 mM	0.1121 mL	0.5604 mL	1.1208 mL	2.8020 mL
	40 mM	0.0841 mL	0.4203 mL	0.8406 mL	2.1015 mL
	50 mM	0.0672 mL	0.3362 mL	0.6725 mL	1.6812 mL
	60 mM	0.0560 mL	0.2802 mL	0.5604 mL	1.4010 mL
	80 mM	0.0420 mL	0.2101 mL	0.4203 mL	1.0507 mL
	100 mM	0.0336 mL	0.1681 mL	0.3362 mL	0.8406 mL

Duloxetine Related Classifications

Help & FAQs

Do most proteins show cross-species activity?
Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Duloxetine116539-59-4LY248686LY 248686LY-248686Serotonin Transporter5-HTTSERTSLC6A4depressivedisordergeneralizedanxietyosteoarthiritismusculoskeletalpainInhibitorinhibitorinhibit

Please select a local distributor ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Product Name			Requested Quantity *
Applicant Name *			Salutation
Email Address *			Phone Number *
Department			Organization Name *
City			State
Country or Region *
Remarks

Product Name			Lot #
Applicant Name *			Email Address *
Phone Number			Department *
Organization Name *			Country or Region *
Remarks

Name
Email *

	Sorry, but the email address you supplied was invalid.

Duloxetine (Synonyms: LY248686)

Customer Review

Other Forms of Duloxetine:

Duloxetine Related Antibodies

12 Publications Citing Use of MCE Duloxetine

Featured Recommendations

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

Biological Activity

Purity & Documentation

References

Customer Review

Duloxetine Related Antibodies

Molarity Calculator

Dilution Calculator

Complete Stock Solution Preparation Table

Duloxetine Related Classifications

Keywords:

Your Recently Viewed Products:

Customer Review

Request for HNMR Report

SAFETY DATA SHEET (SDS)

Request for HNMR Report